China Deproteinized Calf Blood Extract Investigation Market Report 2015

Sep 24, 2015, 13:10 ET from Research and Markets

DUBLIN, Sept. 24, 2015 /PRNewswire/ -- 

Research and Markets (http://www.researchandmarkets.com/research/kj2jgm/investigation) has announced the addition of the "Investigation Report on China's Deproteinized Calf Blood Extract Market, 2010-2019" report to their offering.

Developed by Jaeger KH with membrane filtering technology, deproteinized calf blood extract is the deproteinized blood extract of new- born calf with a relative molecular mass of less than 6000 dalton. Since the 1960s, deproteinized calf blood extract has been marketed all over the world.

Recently, nervous system drug has reported a stable growth. Among the TOP500 drugs in the seven big markets, nervous system drug reported a sales value of USD 43.286 billion with a year- on- year growth of 3% in 2013. Brain system drug, in particular, has undergone a downturn in global market. However, as people become increasingly aware of the pathogenesis and clinical pharmacology of neurologic diseases, the market of neurologic drug has grown fast in China. As a leading neurologic drug, deproteinized calf blood extract has reported a large sales in China. By the end of August 2015, there are 18 manufacturers of deproteinized calf blood extract and deproteinized calf blood extract injection, 3 manufactures of deproteinized calf blood extract ophthalmic gel and 1 manufacturer of deproteinized calf blood extract capsule.

According to this market survey, the sales value of deproteinized calf blood extract in sample hospitals reached about CNY 1.2 billion and CAGR during the period of 2005- 2014 surpassed 30%. Jinzhou Ahon Pharmaceutical Co., Ltd, Heilongjiang Jiangshi Pharmaceutical Co., Ltd, Harbin Sanctity Pharmaceutical Co., Ltd, Jilin Connell Pharmaceutical Co., Ltd and Wuhan Humanwell Pharmaceutical Co., Ltd occupy the market, among which Jinzhou Ahon Pharmaceutical Co., Ltd had the largest market share of about 71% for sales value in 2014.

Key Topics Covered:

1 Related Concepts of Deproteinized Calf Blood Extract

2 Market Profile of Deproteinized Calf Blood Extract in China

3 Survey on the Sales of Deproteinized Calf Blood Extract in China, 2010-2014

4 Survey on Market Share of Major Manufacturers of Deproteinized Calf Blood Extract in China, 2010-2014

5 Survey on Dosage Forms of Deproteinized Calf Blood Extract in China, 2010-2014

6 Reference Price of Deproteinized Calf Blood Extract in Chinese Hospitals in 2014

7 Major Manufacturers of Deproteinized Calf Blood Extract in Chinese Market, 2010-2014

8 Market Outlook of Deproteinized Calf Blood Extract in China, 2015-2019

Companies Mentioned

- Harbin Sanctity Pharmaceutical Co., Ltd
- Heilongjiang Jiangshi Pharmaceutical Co., Ltd
- Jilin Connell Pharmaceutical Co., Ltd
- Jinzhou Ahon Pharmaceutical Co., Ltd
- Shenyang Sinqi Pharmaceutical Co., Ltd
- Wuhan Humanwell Pharmaceutical Co., Ltd

For more information visit http://www.researchandmarkets.com/research/kj2jgm/investigation

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com